SCHEMBL29935775

SCHEMBL29935775

Fc1cccnc1-n1cncn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 1/20 0.47
▸ GLA P06280 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ ADORA3 P0DMS8 1/20 0.39
▸ ADORA2A P29274 1/20 0.39
▸ ADORA2B P29275 1/20 0.39
▸ ADORA1 P30542 1/20 0.39
▸ GRM4 Q14833 1/20 0.39
▸ MAPK1 P28482 1/20 0.37
▸ ALOX5AP P20292 1/20 0.36
▸ KDM4E B2RXH2 3/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ CYP1A2 P05177 2/20 0.35
▸ CYP2C9 P11712 2/20 0.35
▸ CYP2C19 P33261 2/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9826144 0.79 CYP2A6 (0.47) CYP2A6ADORA3ADORA2AADORA2BADORA1
SCHEMBL22421808 0.76 CYP2A6 (0.45) CYP2A6GLAHTTADORA2AADORA1
SCHEMBL3737915 0.75 CYP2A6 (0.44) CYP2A6ADORA3ADORA2AADORA2BADORA1
SCHEMBL3735595 0.75 CYP2A6 (0.44) CYP2A6GRM4KDM4EALDH1A1CYP2C19
SCHEMBL2788049 0.75 CYP2A6 (0.44) CYP2A6HTTGRM4ALOX5APKDM4E
SCHEMBL4556266 0.75 KDM4E (0.47) CYP2A6GLAHTTGRM4MAPK1
SCHEMBL13040175 0.75 CYP2A6 (0.44) CYP2A6GRM4ALOX5APKDM4EALDH1A1
SCHEMBL8237489 0.75 CYP2A6 (0.44) CYP2A6HTTADORA3ADORA2AADORA2B
SCHEMBL12613954 0.74 KDM4A (0.42) HTTADORA3ADORA2AADORA2BADORA1
Hydrochloric Acid SCHEMBL30055532 0.73 CYP2A6 (0.42) CYP2A6GRM4KDM4EALDH1A1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12577243-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2026-03-17 — — US disclosed
US-12384769-B2 Heteroaryl-substituted aminoalkyl azole compounds as pesticides ELANCO ANIMAL HEALTH GMBH (DE) 2025-08-12 — — US disclosed
US-11820766-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-11-21 — — US disclosed
US-20230145249-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2023-05-11 — — US disclosed
US-20230046680-A1 NOVEL HETEROARYL-SUBSTITUTED AMINOALKYL AZOLE COMPOUNDS AS PESTICIDES ELANCO ANIMAL HEALTH GMBH (DE) 2023-02-16 — — US disclosed
US-20220332713-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2022-10-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220332713-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP CYP2A6 747/4885GLA 152/4885HTT 3293/4885
US-20230046680-A1 NOVEL HETEROARYL-SUBSTITUTED AMINOALKYL AZOLE COMPOUNDS AS PESTICIDES DDT, CRY1, CYP4F3 CYP2A6 239/4885GLA 3992/4885HTT 1388/4885
US-12384769-B2 Heteroaryl-substituted aminoalkyl azole compounds as pesticides DDT, CRY1, AAAS CYP2A6 225/4885GLA 3884/4885HTT 1081/4885
US-12577243-B2 Monoacylglycerol lipase modulators MGLL, LPL, FAAH CYP2A6 555/4885GLA 427/4885HTT 3651/4885
US-20230145249-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP CYP2A6 747/4885GLA 152/4885HTT 3293/4885
US-11820766-B2 Monoacylglycerol lipase modulators MGLL, LPL, PNLIP CYP2A6 747/4885GLA 152/4885HTT 3293/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback